VOLORIDGE INVESTMENT MANAGEMENT, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 259 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$2,846,685
-19.4%
109,530
-5.1%
0.01%
-21.4%
Q4 2023$3,530,383
-2.2%
115,372
+14.0%
0.01%
-17.6%
Q2 2023$3,608,542
-59.7%
101,193
-71.3%
0.02%
-62.2%
Q1 2023$8,958,936
+60.7%
352,714
+156.6%
0.04%
+45.2%
Q4 2022$5,574,282
+118.6%
137,433
+78.1%
0.03%
+121.4%
Q3 2022$2,550,000
-72.5%
77,154
-70.7%
0.01%
-70.8%
Q2 2022$9,259,000
+168.3%
262,978
+250.5%
0.05%
+140.0%
Q1 2022$3,451,000
+358.3%
75,035
+560.3%
0.02%
+400.0%
Q4 2021$753,000
-93.8%
11,363
-94.2%
0.00%
-94.9%
Q3 2021$12,137,000
-12.9%
194,413
+15.6%
0.08%
-19.6%
Q2 2021$13,927,000
-36.9%
168,154
-49.5%
0.10%
-39.8%
Q1 2021$22,084,000
+211.7%
333,045
+260.6%
0.16%
+172.9%
Q4 2020$7,086,000
+134.9%
92,355
-11.9%
0.06%
-32.2%
Q1 2020$3,017,000
-52.6%
104,849
+4.4%
0.09%
-29.8%
Q4 2019$6,368,000
+346.9%
100,400
+86.7%
0.12%
+217.9%
Q2 2019$1,425,000
-10.8%
53,790
-38.2%
0.04%
-18.8%
Q1 2019$1,597,00087,0170.05%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders